The 14 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 60.00, with a high estimate of 74.00 and a low estimate of 30.00. The median estimate represents a +133.74% increase from the last price of 25.67.
The current consensus among 14 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.85
Reporting Date Nov 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.